Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe. The aim of this trial was to investigate safety and
pharmacokinetics of multiple doses of catridecacog (recombinant factor XIII, rFXIII) in
healthy volunteers.